Fairway has committed to developing an innovative technology for medical imaging using a combination of light and ultrasound.  This technology, known as Optoacoustic Imaging, Sensing and Monitoring, is based on the ability to generate ultrasonic pressure waves with spatial profiles that replicate the distribution of absorbed optical energy by illuminating tissue with short duration (nanosecond) pulses of red or near-infrared light.  With high optical contrast of blood distribution in tissues and high spatial resolution delivered through detection of ultrawide-band ultrasound, optoacoustic imaging delivers functional images of tissue with details that cannot be provided and at the depths that cannot be reached by pure optical imaging methods. 

Optoacoustic technology, when fully refined, will find a wide range of clinical applications and also will be used a tool in preclinical research.  Natural combination of optoacoustic and ultrasonic imaging in one modality will provide comprehensive information on tissue structure and function, making tissue characterization for diagnostic purposes more accurate.  The value of such coregistered information from the dual OA/US modality will be on par with PET/CT or MRI/fMRI but achievable at significantly lower cost.  Fairway is a leader in the R&D efforts for this technology.  We currently have eight PhD Research Scientists on staff dedicated to this work and we have collaboration agreements with a variety of major institutions and academic investigators nationwide and internationally.

Optoacoustic profile replicates tissue layered structure and provides functional information on blood concentration and its oxygen saturation.